Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site study.
In the near future, patients won’t have to waste time and be disappointed with months of ineffective therapy, scientists said.
“Now we can start to predict which drugs a patient will respond to,” said co-senior author Harris Perlman, chief of rheumatology at Northwestern University Feinberg School of Medicine. “We can truly do precision medicine for rheumatoid arthritis. I believe this could be game changing. ”
The paper was recently published as an uncorrected proof in Arthritis & Rheumatology and will be officially published in the journal in late May. Richard Pope and Deborah Winter also are lead Northwestern authors.
Treatment for rheumatoid arthritis now is trial and error.
“We have so many different biologic drugs and there’s no rhyme or reason to give one drug versus the other,” Perlman said. “We waste $2.5 billion a year in ineffective therapy. And patients go through 12 weeks of therapy, don’t respond and get upset.”
Scientists in the multi-site study were the first in the U.S. to use ultrasound-guided therapy to take a tissue biopsy in the affected joint. In the past, blood samples were used to try to determine the effectiveness of the therapy and disease progression.
“It’s just like oncology, where you go to the tumor,” Perlman said. “Why go anywhere else? In rheumatoid arthritis, we’ve never gone to the target organ.”
Improved ultrasound guided techniques make the new technique possible, Perlman said, noting joint biopsies began in Europe about six years ago.
Scientists in the six-site study analyzed the tissue in 41 rheumatoid arthritis patients, separating out different immune cell populations. They focused on macrophages, essentially the garbage collectors of the immune system that are overactive in rheumatoid arthritis. These cells produce toxic, inflammatory proteins that destroy the joints. Biologic therapy removes the protein molecules being secreted by the macrophages.
The study included 30 patients from Northwestern and the remaining 11 from the University of Alabama at Birmingham; Washington University, Columbia University, Mayo Clinic and University of Michigan.
In the past, scientists have tried to determine therapeutic effectiveness by separating patients into groups based on their clinical parameters such as what antibodies they are producing against themselves, how swollen their joints are and medications they are taking. Then scientists tried to see if these parameters could predict therapeutic efficacy. But that hasn’t worked, Perlman said.
Instead, Perlman and colleagues segregated patients based on the genes being produced by their macrophages. They identified two patient groups who shared aspects of the genetic profiles.
Next, the scientists identified which of these patient populations had joints that were getting better and what biologic therapies they were taking. They also identified a gene sequence associated in patients with early disease. The earlier the patient is treated, the more effective the therapy.
The next goal is to predict which patients will have the best response — based on their genetic signature — to a specific drug.
In a new study, researchers are taking joint biopsy tissue from patients at the start of a new therapy and then six weeks later to see if they can find a predictor gene sequence that will clearly identify which patients respond to a particular therapy.
“The idea is to develop gene sequences to predict whether a patient will respond or not,” Perlman said. “Our goal is that this procedure will become the standard of care of for all patients with rheumatoid arthritis.”
Learn more: Rheumatoid arthritis meets precision medicine
The Latest on: Rheumatoid arthritis
via Google News
The Latest on: Rheumatoid arthritis
Rheumatoid Arthritis Stem Cell Therapy Market to Witness a Pronounce Growth During to 2018 to 2028
on July 18, 2018 at 1:53 pm
Rheumatoid arthritis is one of the many types of arthritis and is an autoimmune disorder. In patients with rheumatoid arthritis, the immune system attacks different parts of joints by generating cellu... […]
Wellness Wednesday: Rheumatoid arthritis
on July 18, 2018 at 7:26 am
Rheumatoid arthritis is an inflammatory and autoimmune condition with levels of inflammation that can affect a person's joints and the rest of their body. However, many don't know your brain plays a r... […]
Rheumatoid Arthritis Diagnosis Tests Market is Expected to expand at a CAGR of 6.3% during 2017–2027
on July 18, 2018 at 4:50 am
The market is segmented based on test type, end user and region. On the basis of test type, the market has been segmented into two segments such as serology tests and monitoring RA treatment efficienc... […]
Experts Warn Against Arthritis Symptoms for Early Detection
on July 18, 2018 at 2:30 am
Experts warn against arthritis symptoms for early detection. Rheumatoid arthritis, osteoarthritis, and gout are the most common forms of arthritis. These conditions affect millions of people in the Un... […]
Popular Arthritis Drug Could Wreak Havoc on Liver Health
on July 18, 2018 at 2:16 am
There are many pharmaceutical drugs used for arthritis, such as biologic medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and disease modifying antirheumatic drugs (DMARDs). DMARDs work by ... […]
Epic bucket list challenge for Brick woman with Rheumatoid arthritis
on July 16, 2018 at 6:54 am
Epic bucket list challenge for Brick woman with Rheumatoid arthritis Christine Conti of Brick enters the Ironman Competition after crippling diagnosis Check out this story on app.com: https://on.app.c... […]
Europe Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2018 - ResearchAndMarkets.com
on July 13, 2018 at 10:02 am
DUBLIN--(BUSINESS WIRE)--The "Europe Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The researcher announced the result... […]
Rheumatoid Arthritis: What CRP Levels Say About You
on July 12, 2018 at 4:29 pm
Rheumatoid arthritis (RA) is a type of arthritis that can affect anyone at any age. However, it’s more common in women and often first appears in middle age. Like other types of arthritis, RA causes s... […]
Rheumatoid arthritis - 95p essential oil could relieve joint pain and inflammation
on July 12, 2018 at 1:45 pm
RHEUMATOID arthritis symptoms could be reduced by making changes to your diet plan, it’s been claimed. This cheap fruit essential oil could help to prevent or relieve painful signs or symptoms of rheu... […]
via Bing News